Investigational Site Number 410003

Seoul 152-703

0 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndrome, Cancer, Hematopoietic Neoplasm, Idiopathic Pulmonary Fibrosis, Non-small Cell Lung Cancer, Rheumatoid Arthritis, Small Cell Lung Cancer, Type 2 Diabetes Mellitus, Venous Thromboembolism

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia — Completed
• Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) — Completed
• Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications — Completed
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
• Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer — Completed
• Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer — Completed
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed